Medicinal Products

ASPEGIC Adult 1,000 mg

Generic drug of the therapeutic class: Analgesics
active ingredients: DL-lysine acetylsalicylate
laboratory: Sanofi-Aventis France

Powder for oral solution
Box of 30 sachets-dose
All forms


· Symptomatic treatment of mild to moderate pain and / or febrile conditions.

· Symptomatic treatment of inflammatory rheumatism.

Dosage ASPEGIC Adult 1000 mg Powder for oral solution Box of 30 sachets-dose

Administration mode

Oral way.

Pour the contents of the sachet into a glass and add a small amount of drink (eg water, milk, fruit juice).


Reserved for adults and children from 50 kg (approximately 15 years)

Pains of mild to moderate intensity and / or febrile states:

· For adults and children weighing more than 50 kg (from about 15 years old):
The maximum recommended daily dosage is 3 g of acetylsalicylic acid, 3 sachets per day.
The usual dosage is 1 sachet to 1 g, to renew if necessary after 4 hours minimum, without exceeding 3 sachets per day.

· For elderly subjects:
The maximum recommended daily dosage is 2 g of acetylsalicylic acid, 2 sachets per day.
The usual dosage is 1 sachet to 1 g, to renew if necessary after 4 hours minimum, without exceeding 2 sachets per day.

Frequency of administration:

Systematic catches prevent pain or fever from oscillating: they should be spaced at least 4 hours apart.

Duration of treatment: the patient must be informed not to use acetylsalicylic acid more than 3 days in case of fever and 5 days in case of pain without the opinion of a doctor or a dentist.

Rheumatic conditions:

3 to 6 g maximum per day to be divided into 3 or 4 taken at least 4 hours apart.

In the elderly, the dosage will be reduced.

Against indications

This medicine is CONTRAINDICATED in the following situations:

· Hypersensitivity to acetylsalicylic acid or any of the excipients, or other nonsteroidal anti-inflammatory drugs (cross-reactive),

· History of asthma caused by salicylates or substances of similar activity, including nonsteroidal anti-inflammatory drugs,

· Third trimester of pregnancy (beyond 24 weeks of amenorrhea) for doses greater than 100 mg per day (see section on Pregnancy and lactation ),

· Evolving gastroduodenal ulcer,

· Any constitutional or acquired haemorrhagic disease,

· Haemorrhagic risk,

· Severe liver failure,

· Severe renal insufficiency,

· Severe uncontrolled heart failure,

· In combination with methotrexate at doses greater than 20 mg / week (see section 4.5 ), and for anti-inflammatory doses (≥ 1 g per dose and / or ≥ 3) g per day) or for analgesic or antipyretic doses (≥ 500 mg per dose and / or <3 g per day) of acetylsalicylic acid,

· In combination with oral anticoagulants for anti-inflammatory doses of acetylsalicylic acid (≥ 1 g per dose and / or ≥ 3 g daily), or for analgesic or antipyretic doses (≥ 500 mg per dose and / or < 3 g per day) in a patient with a history of peptic ulcer disease (see section 4.5 Interactions with other medicinal products and other forms of interaction ).

Adverse effects Aspegic Adult

The frequency of adverse events can not be estimated. As a result, the frequencies are referenced as indeterminate.

Blood and lymphatic system disorders

· Hemorrhagic syndromes (epistaxis, gingivorragies, purpura ...) with increased bleeding time. This action persists for 4 to 8 days after stopping acetylsalicylic acid. It can create a haemorrhagic risk in case of surgery.

· Intracranial and gastrointestinal bleeding may also occur.

Immune system disorders

· Hypersensitivity reactions,

· Anaphylactic reactions,

· Asthma,

· Quincke's edema.

Nervous system disorders

· Headache, dizziness.

· Feeling of decreased hearing.

· Tinnitus.

which are usually the mark of an overdose.

· Intracranial hemorrhages.

Gastrointestinal disorders:

· Abdominal pain.

· Digestive or occult digestive haemorrhages (hematemesis, melena ...), responsible for iron deficiency anemia. These haemorrhages are all the more frequent as the dosage is higher.

· Gastric ulcerations and perforations.

Hepatobiliary disorders

· Liver damage, mainly hepatocellular.

· Increased liver enzymes.

Skin and subcutaneous tissue disorders

· Urticaria.

· Skin reactions.

General disorders and administration site conditions

· Reye's Syndrome (see Warnings and Precautions section )

Popular Posts

Category Medicinal Products, Next Article